ADA and breast cancer: The top 15 drugs with high negative correlations in the ER+ BC cell line MCF7 were obtained, including the microtubule stabilizing agent epothilone A, the phosphodiesterase inhibitor zaprinast, the NF-kB pathway inhibitor parthenolide and the adenosine deaminase inhibitor EHNA.